KKR Sinks Its Teeth Into Henry Schein

Henry Schein gets $250 million investment from private equity firm KKR
Private equity firm KKR & Co. Inc. has invested $250 million in Henry Schein Inc., Long Island’s largest publicly traded company by revenue, the Melville-based company announced Wednesday.
KKR Sinks Its Teeth Into Henry Schein With Additional Investment And Board Seats: Details
Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor disclosed a strategic investment of an additional $250 million from funds affiliated with KKR & Co.
KKR builds stake in Henry Schein, reaches deal to add board seats
Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the distributor of medical products said on Wednesday.
KKR To Become 12% Shareholder In Henry Schein With Additional $250M Investment: Retail Cheers The Deal
Shares of KKR & Co Inc (KKR) and Henry Schein drew retail attention on Wednesday after it was revealed that the private equity giant will become a 12% common shareholder in the healthcare solutions firm.
KKR Takes Strategic Stake in Medical Supplier Henry Schein
KKR & Co. has taken a 12% stake in Henry Schein Inc. and will work with the company to improve operations at the world’s largest distributor of medical products to office-based dentists and doctors.
Henry Schein gets a major private equity investment
Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and distributor.
KKR builds stake in Henry Schein, agrees deal for board seats, WSJ reports
Private equity firm KKR has taken a large stake in Henry Schein and plans to work with the distributor of medical products to improve its operations, the Wall Street Journal reported on Wednesday citing people familiar with the matter.
Hold Rating on Henry Schein Amid KKR Investment and Market Uncertainties
In a report released on January 29, Michael Cherny from Leerink Partners reiterated a Hold rating on Henry Schein (HSIC – Research Report),
KKR Builds Stake in Henry Schein, Reaches Deal for Board Seats, WSJ Reports
(Reuters) - Private-equity firm KKR has taken a large stake in Henry Schein and plans to work with the distributor of healthcare products to improve its operations, the Wall Street Journal reported on Wednesday citing people familiar with the matter.
Hold Rating Maintained for Henry Schein Amid Strategic Investment by KKR and Soft Operational Performance
Mizuho Securities analyst Steven Valiquette has maintained their neutral stance on HSIC stock, giving a Hold rating on January 23.Invest with ...
HME News4d
Henry Schein receives funding
Henry Schein has received a strategic investment of $250 million from KRR, giving the global investment firm a 12% stake in the company, with the option to purchase additional shares ...
KKR将收购Henry Schein 12%股权
纽约梅尔维尔 - 全球投资公司KKR即将成为Henry Schein, Inc.的重要股东。Henry Schein是全球最大的为办公室牙科和医疗从业者提供医疗保健解决方案的供应商。通过2.5亿美元的新战略投资，KKR将持有该公司12%的股份，成为最大的非指数基金股东。根据 InvestingPro 数据，Henry ...
Henry Schein price target raised to $90 from $82 at Barrington
Barrington analyst Michael Petusky raised the firm’s price target on Henry Schein (HSIC) to $90 from $82 and keeps an Outperform rating on the ...